Your browser doesn't support javascript.
loading
Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Escudero-Esparza, Astrid; Bartoschek, Michael; Gialeli, Chrysostomi; Okroj, Marcin; Owen, Sioned; Jirström, Karin; Orimo, Akira; Jiang, Wen G; Pietras, Kristian; Blom, Anna M.
Affiliation
  • Escudero-Esparza A; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Bartoschek M; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Gialeli C; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Okroj M; Department of Medical Biotechnology, Medical University of Gdansk, Gdansk, Poland.
  • Owen S; Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
  • Jirström K; Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Orimo A; Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.
  • Jiang WG; Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
  • Pietras K; Department of Laboratory Medicine, Lund University, Lund, Sweden.
  • Blom AM; Department of Translational Medicine, Lund University, Malmö, Sweden.
Oncotarget ; 14: 481-482, 2023 May 19.
Article in En | MEDLINE | ID: mdl-37204255
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2023 Document type: Article Affiliation country: Suecia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2023 Document type: Article Affiliation country: Suecia